All News

Avidin succesfully completed project of EUREKA Innovation Award (E!12655 MITOME)

Avidin has detected new Delta variant in Hungary

Distribution ended for AKSCI products

Avidin has now developed a method for measuring B-cell immunity.

Q134R: Small chemical compound with NFAT inhibitory properties improves behavioral performance and synapse function in mouse models of amyloid pathology.

Avidin has developed a novel blood based diagnostic test that measures acquired T-cell immunity against the SARS-CoV2 coronavirus, following infection or immunization. Avidin is the first private company to offer such a test in Hungary.

Avidin’s Budapest site (Berlini u 47-49) was accredited as M3 authorization level of microbiological diagnostics laboratory.

Avidin’s enthusiastic team has participated in Hungarian Shoe Box Campaign, a child-assisting program, under which Christmas presents are donated to children in need.

The aim of the project was the acquisition of the Advia Centaur® XPT immunochemical automate system manufactured by Siemens, followed by the adaptation of the test assays provided by the instrument.